Santos, A.R.M.; Cruz, A.G.; Camargo, F.N.; Santos, J.D.M.; Model, J.F.A.; Silva, J.F.T.; Matos, S.L.; Araujo, L.C.C.; Camporez, J.P.
Modified Citrus Pectin-Mediated Gal-3 Reduction Attenuates Metabolic Dysfunction-Associated Steatohepatitis in an Experimental Model. Cells 2026, 15, 1544.
https://doi.org/10.3390/cells15171544
AMA Style
Santos ARM, Cruz AG, Camargo FN, Santos JDM, Model JFA, Silva JFT, Matos SL, Araujo LCC, Camporez JP.
Modified Citrus Pectin-Mediated Gal-3 Reduction Attenuates Metabolic Dysfunction-Associated Steatohepatitis in an Experimental Model. Cells. 2026; 15(17):1544.
https://doi.org/10.3390/cells15171544
Chicago/Turabian Style
Santos, Anne R. M., Alessandra G. Cruz, Felipe N. Camargo, Jessica D. M. Santos, Jorge F. A. Model, José F. T. Silva, Sandro L. Matos, Layanne C. C. Araujo, and João Paulo Camporez.
2026. "Modified Citrus Pectin-Mediated Gal-3 Reduction Attenuates Metabolic Dysfunction-Associated Steatohepatitis in an Experimental Model" Cells 15, no. 17: 1544.
https://doi.org/10.3390/cells15171544
APA Style
Santos, A. R. M., Cruz, A. G., Camargo, F. N., Santos, J. D. M., Model, J. F. A., Silva, J. F. T., Matos, S. L., Araujo, L. C. C., & Camporez, J. P.
(2026). Modified Citrus Pectin-Mediated Gal-3 Reduction Attenuates Metabolic Dysfunction-Associated Steatohepatitis in an Experimental Model. Cells, 15(17), 1544.
https://doi.org/10.3390/cells15171544
